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choice of a large ring thus is variable by surgeon. Although the
average A2 height in our series (29 mm) corresponds most
closely to a 34 Myxo-ETlogix ring, larger than the largest
Physio ring (27 mm), we commonly used smaller Myxo-
ETlogix rings instead of large Physio rings because of the
perceivedbenefit of the4-mmP2displacementwith theMyxo-
ETlogix ring to reduce the risk of SAM. Whether it is the P2
displacement or the large size of the Myxo-ETlogix ring that
accounts for our low incidence of SAM is not yet clear.
Study Limitations
This was a nonrandomized study of the initial use of a new
commercially available ring, but not all ring sizes were avail-
able during the study period. The inventor of the ring was the
surgeon in the vast majority of cases, and we attempted to re-
duce this bias with direct quantitative measurements and
standard echocardiographic reporting. The data in all tables
and figures therefore represent unbiased measurements and
clinical results. A randomized trial is certainly feasible but
would be best performed at another institution, albeit with
experienced surgeons.
In summary, a new ring was introduced with a change in
our clinical practice. The result was simpler MV repair pro-
cedures, rare nonobstructive SAM, and excellent clinical
and echocardiographic results. Further confirmation at other
centers is pending, and late echocardiographic follow-up is
ongoing.
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Dr Aidan A. Raney (Newport Beach, Calif). I enjoyed this presen-
tation very much. Dr McCarthy is making a major contribution. As
he mentioned, the repairability rate of valves in this country is in the2008
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A
CD40% to 50% range. However, if the most complex valves with ex-
cessive tissue are included, the overall repairability rate is probably
going to be significantly lower, maybe in the 30% range. This device
is a tremendous advance. Not only does it simplify the procedure but
it also reduces the risk of SAM.
Whenwe looked at our series of over 200 patients about 11/2 years
ago, we also had about a 5% incidence of SAM that required a sec-
ond pump run and correction.
I have a few questions for you. In your series, are you repairing
all the myxomatous valves with the Myxo-ETlogix ring or do you
have a sense of certain valve characteristics that would preclude
using this device?
Dr McCarthy. Right now, we look at the leaflet and annulus
size. In the majority of these patients with myxomatous leaflets,
something is elongated. The valves do not always fall into that cat-
egory of fibroelastic deficiency, so that it may be an elongated ante-
rior leaflet but not a very elongated posterior, or the other way
around. I use the Physio ring when the remaining valve is normal:
the anterior leaflet, P1 and P3, are normal, and we have resected
the abnormal part, which is usually a flail involving P2.
Dr Raney. Do you think that there is less modification of the
annulus with this device, that is, without quadrangular resection and
a plication of the posterior annulus? Because sizing can be a prob-
lem, do you think that transesophageal echocardiography before
the repair will provide a good indication of what size of a Myxo-
ETlogix ring to use?
Dr McCarthy. We are collecting a big database on our MV
repairs, and we are also going to correlate it with what echocardiog-
raphy measures. So far, it looks very good. When we measure A2 at
29 mm, the echocardiographer measures it at roughly the same. We
hope to get to a point where the echocardiographer can identify theThe Journal of Thoheight of the anterior and posterior leaflets and we can then prescribe
the right sized ring.
Dr Raney. We have used this ring now in 8 cases, and I have
been very impressed with the efficacy and the efficiency of the ring.
DrMichaelMack (Dallas, Tex).DrMcCarthy, do you have any
experience using this ring with artificial chords and does that make
sense?
DrMcCarthy. I think it makes sense. I do not really use artificial
chords very much. I am still pretty classic and I do chordal transfer.
However, some surgeons are using artificial chords with the ring. If
artificial chords are used on the posterior leaflet where there is an
elongated P2 segment that is not being replaced, I think this would
make sense, because otherwise, as you could see from the AP diam-
eter, a 40-mm Physio ring is not nearly big enough for that group of
patients.
Dr Mack. Is this ring generally available?
Dr McCarthy. It is in the United States now.
Dr Jen-Ping Chang (Kaohsiung, Taiwan). We all know that
Professor Carpentier repairs the Barlow valves by banding the septal
portion of the classic ring anteriorly, and we know your ring is just
like bending the posterior portion of the ring posteriorly. What is the
difference between the anterior displacement and the posterior
displacement of this ring?
Dr McCarthy. The anterior displacement that Dr Carpentier
does periodically is variable: he could bend it just a little bit or he
could bend it quite a bit. It seemed to us most of the reduction should
be more posterior rather than anterior, and so when we designed the
ring, that is where we put it. Also, remember on the classic ring when
Dr. Carpentier bends it that way, that is the only place he can bend it
because that is where the break is in the ring. So it is the only part
that is practical.racic and Cardiovascular Surgery c Volume 136, Number 1 81
